New Light Technology for Brain Tumor Surgery
Author Information
Author(s): José Pedro Lavrador, Francesco Marchi, Ali Elhag, Nida Kalyal, Engelbert Mthunzi, Mariam Awan, Oliver Wroe-Wright, Alba Díaz-Baamonde, Ana Mirallave-Pescador, Zita Reisz, Richard Gullan, Francesco Vergani, Keyoumars Ashkan, Ranjeev Bhangoo
Primary Institution: Department of Neurosurgery, King’s College Hospital NHS Foundation Trust, London, UK
Hypothesis
Can the Nico Myriad Spectra System improve the outcomes of high-grade glioma surgery?
Conclusion
The new in situ light-source delivery technology enhances tumor visualization and may improve surgical outcomes for patients with high-grade gliomas.
Supporting Evidence
- 85.71% of patients showed fluorescence during surgery.
- 57.15% achieved Gross Total Resection (GTR).
- New technology allows for better visualization of tumors.
- Integration with existing surgical tools enhances functionality.
- Improved identification of satellite lesions in multifocal gliomas.
Takeaway
This study shows that a new light system helps doctors see brain tumors better during surgery, which might help them remove more of the tumor.
Methodology
This is a retrospective single-centre study involving 35 patients who underwent surgery with the Nico Myriad Spectra System.
Limitations
Potential for false negatives due to light source obstruction and alignment issues.
Participant Demographics
The study included 35 patients, with 15 females (42.85%) and 20 males (57.15%), mean age 52.6 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website